SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-23-000053
Filing Date
2023-08-09
Accepted
2023-08-09 16:09:19
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20230630.htm   iXBRL 10-Q 1272935
2 EX-31.1 CEO CERTIFICATION plrx-20230630xex311.htm EX-31.1 10445
3 EX-31.2 CFO CERTIFICATION plrx-20230630xex312.htm EX-31.2 10413
4 EX-32.1 CEO AND CFO CERTIFICATION plrx-20230630xex321.htm EX-32.1 7294
  Complete submission text file 0001746473-23-000053.txt   5813192

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20230630.xsd EX-101.SCH 46674
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20230630_cal.xml EX-101.CAL 50492
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20230630_def.xml EX-101.DEF 212716
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20230630_lab.xml EX-101.LAB 508890
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20230630_pre.xml EX-101.PRE 357809
68 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20230630_htm.xml XML 621991
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 231155197
SIC: 2834 Pharmaceutical Preparations